Home » Stocks » NPTX

Neuropathix, Inc (NPTX)

Stock Price: $0.1900 USD -0.0100 (-5.00%)
Updated Jan 20, 2021 3:59 PM EST - Market closed
Market Cap 13.55M
Revenue (ttm) n/a
Net Income (ttm) -3.71M
Shares Out 74.26M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 20
Last Price $0.1900
Previous Close $0.2000
Change ($) -0.0100
Change (%) -5.00%
Day's Open 0.2100
Day's Range 0.1900 - 0.2275
Day's Volume 147,934
52-Week Range 0.13 - 0.545

News

There are no news available yet.

About NPTX

Neuropathix, a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics from its proprietary cannabinoid product platform. It engages in the research and development of chemical entities, such as KLS-13019, as well as its related molecules; and synthetic cannabidiol therapeutics through pre-clinical drug discovery and development processes for use in the disease indications of overt hepatic encephalopathy, chronic traumatic encephalopathy, and chemotherapy induced peripheral neuropathy. The c... [Read more...]

Industry
Biotechnology
Founded
2010
CEO
Dean Petkanas
Employees
5
Stock Exchange
OTCMKTS
Ticker Symbol
NPTX
Full Company Profile

Financial Performance

Financial Statements